The one thing i will give to Akki is they have a general scientific knowledge.. general only.. (ie “placebo effect can cure cancer” lol, it has happened but i’m not betting on a 1 in 1 million chance) but akki has zero ability to price risk / reward scenarios which is what early stage investing is all about.
The current price vs potential future outcomes..
Akki thinks everyone should just expect zero positive outcomes until the placebo controlled P2 is finished in 2 years and ANP should stay at $20m until then... then the day of the results, should be $0 or $3bn.. with nothing in between..
I have looked way back through your posts akki and your value add is low.
Can you offer some future scenarios and how these different risk/reward events may be interpreted via the share price?
Spare the cheap one liners please.
Companies competing with ANP in DMD space, page-8
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $119.8K | 888.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 610570 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 615712 | 9 |
View Market Depth
| Last trade - 13.45pm 14/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |